BiomedicineNews.net

Biomedicine Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Breast cancer"

Using a novel three-part screening process, researchers at Dana-Farber Cancer Institute have identified a gene that is made inappropriately in about a third of all breast cancers. The discovery, reach ...


Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered new molecular evidence of the role of the hormone prolactin in breast cancer. They have found that prolactin, a pi ...


Breast cancer is characterised by genomic alterations. Researchers did a multicentre molecular screening study to identify abnormalities in individual patients with the aim of providing targeted thera ...


GP2 is a HER2 derived, HLA-A2+-restricted immunogenic peptide designed to stimulate CD8+T cells to recognize tumor cells with any level of HER2 expression ( IHC 1-3+ ). Accrual to a prospective, rando ...


Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to re-stimulate the immune system to recognize cancer cells and target them for dest ...


Chimeric antigen receptor ( CAR ) T cell immunotherapy has demonstrated profound results in hematologic malignancies but clinical efficacy in the solid tumor setting has not been observed. Barriers t ...


A novel approach to immunotherapy developed by researchers at the National Cancer Institute ( NCI ) has led to the complete regression of breast cancer in a patient who was unresponsive to all other t ...